C. Escuriola‐Ettingshausen

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters et al. · Blood · 2013 · 215 citations · Full text

Medicine, Genetics, Hematology +16

When should prophylactic treatment in patients with haemophilia A and B start?— The German experience

C. A. Lee, C. M. Kessler, D. Varon et al. · Haemophilia · 1998 · 156 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab

Manuel Carção, C. Escuriola‐Ettingshausen, Elena Santagostino et al. · Haemophilia · 2019 · 95 citations · Full text

Medicine, Hematology, Immunology +13

Inhibitor development and mortality in non‐severe hemophilia A

Corien L. Eckhardt, J.I. Loomans, Alice S. van Velzen et al. · Journal of Thrombosis and Haemostasis · 2015 · 76 citations · Full text

Medicine, Hematology, Pharmacology +16

Epidemiology of Inhibitors in Haemophilia A

W. Kreuz, C. Escuriola‐Ettingshausen, I. Martinez‐Saguer et al. · Vox Sanguinis · 1996 · 55 citations

Medicine, Hematology, Clinical Epidemiology +9